IRIS
LACQUANITI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.938
NA - Nord America 5.478
AS - Asia 2.943
SA - Sud America 908
AF - Africa 102
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.379
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.374
RU - Federazione Russa 3.267
SG - Singapore 1.137
CN - Cina 972
BR - Brasile 776
IE - Irlanda 687
SE - Svezia 644
HK - Hong Kong 289
DE - Germania 275
IT - Italia 271
FR - Francia 202
FI - Finlandia 157
GB - Regno Unito 146
VN - Vietnam 145
IN - India 121
UA - Ucraina 81
PL - Polonia 73
AR - Argentina 50
CA - Canada 48
BD - Bangladesh 39
TR - Turchia 39
MX - Messico 32
BE - Belgio 29
ZA - Sudafrica 29
IQ - Iraq 27
EC - Ecuador 24
ES - Italia 21
CZ - Repubblica Ceca 19
JP - Giappone 19
MA - Marocco 19
ID - Indonesia 18
CO - Colombia 17
PK - Pakistan 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
NL - Olanda 15
KE - Kenya 13
VE - Venezuela 13
AT - Austria 12
AZ - Azerbaigian 8
IL - Israele 8
PE - Perù 8
PH - Filippine 8
JO - Giordania 7
TN - Tunisia 7
UY - Uruguay 7
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
EG - Egitto 6
JM - Giamaica 6
PS - Palestinian Territory 6
SA - Arabia Saudita 6
AU - Australia 5
DZ - Algeria 5
KG - Kirghizistan 5
AM - Armenia 4
BG - Bulgaria 4
BH - Bahrain 4
CH - Svizzera 4
CL - Cile 4
HN - Honduras 4
NI - Nicaragua 4
SN - Senegal 4
BO - Bolivia 3
BY - Bielorussia 3
GA - Gabon 3
GY - Guiana 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AO - Angola 2
BN - Brunei Darussalam 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
IR - Iran 2
IS - Islanda 2
KR - Corea 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CR - Costa Rica 1
Totale 15.369
Salva come PNG Salva come JPEG
Città #
Ashburn 973
Moscow 868
Dublin 687
Singapore 628
Dallas 589
Chandler 587
San Jose 347
Beijing 339
Nyköping 326
Hong Kong 289
New York 227
Jacksonville 225
The Dalles 158
Dearborn 128
Los Angeles 125
Ann Arbor 119
Munich 104
Princeton 103
Lauterbourg 101
Medford 101
Cambridge 97
Messina 97
Des Moines 72
São Paulo 61
Warsaw 61
Boardman 54
Buffalo 47
Houston 47
Bremen 46
Jinan 45
Ho Chi Minh City 44
San Mateo 44
Shenyang 38
Tianjin 38
Turku 36
Orem 35
Pune 35
Lancaster 34
Hyderabad 32
Shanghai 32
Redondo Beach 31
Frankfurt am Main 30
Guangzhou 30
Hanoi 30
Wilmington 28
Brussels 27
Rio de Janeiro 25
Woodbridge 25
Hebei 24
Seattle 24
Brooklyn 23
Lentini 22
Nanjing 22
Santa Clara 22
Curitiba 21
Helsinki 21
Belo Horizonte 20
Brasília 20
Council Bluffs 20
Düsseldorf 20
Denver 18
Tokyo 18
Chennai 17
Poplar 17
San Francisco 16
Stockholm 16
Milan 15
Montreal 15
Ningbo 15
Hangzhou 14
London 14
Shenzhen 14
Tashkent 14
Zhengzhou 14
Ankara 13
Nanchang 13
Phoenix 13
Atlanta 12
Baghdad 12
Johannesburg 12
Porto Alegre 12
Boston 11
Haikou 11
Istanbul 11
Jakarta 11
Jiaxing 11
Amsterdam 10
Charlotte 10
Chicago 10
Nairobi 10
Nuremberg 10
Rome 10
Toronto 10
Wroclaw 10
Brno 9
Campinas 9
Ribeirão Preto 9
Vienna 9
Baku 8
Bexley 8
Totale 8.995
Salva come PNG Salva come JPEG
Nome #
3 Tesla-Diffusion Tensor Imaging in Autosomal Dominant Polycystic Kidney Disease: The Nephrologist's Point of View 287
Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. 263
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 226
[From hyponatremia to tolvaptan] 225
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 223
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 222
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation 210
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 209
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 204
Dialysis and the Elderly: An Underestimated Problem. 197
Sclerostin levels in uremic patients: a link between bone and vascular disease 197
Central precocious puberty: from physiopathological mechanisms to treatment. 193
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? 192
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 191
Down with the erythropoietin. Long live the erythropoietin! 185
High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis 185
Fibrosis, regeneration and cancer: what is the link? 184
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 178
A Biotechnological T-Shirt Monitors the Patient's Heart during Hemodialysis. 177
Emerging markers of cachexia predict survival in cancer patients. 176
A new therapy for kidney injury: regeneration. 176
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children 176
La Genotossicità nel Paziente Uremico: un modello di studio sorprendente. 174
Hydrocarbons and kidney damage: Potential use of neutrophil gelatinase-associated lipocalin and sister chromatide exchange 174
Kidney disease and psoriasis: novel evidences beyond old concepts 173
Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: Serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment 173
Before and after preeclampsia: What biomarkers are there? 171
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 170
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 169
Erythropoietin and the truths of science. 166
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 166
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 166
The Myth of Water and Salt: From Aquaretics to Tenapanor 166
The erythropoietin and regenerative medicine: a lesson from fish 165
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 164
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 162
From chronic kidney disease to transplantation: the roles of obestatin. 160
High-mobility group box 1 in allergic and non allergic upper airway inflammation 160
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 158
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 157
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 155
[Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)] 154
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 152
Persistent left superior vena cava and partially left inferior vena cava: A case report of a dangerous central venous catheterization 152
From water to aquaretics: a legendary route. 151
Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker 150
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 149
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 148
Kidney-lung connections in acute and chronic diseases: current perspectives 148
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 147
Malnutrition in the elderly patient on dialysis. 145
Non-Invasive Imaging for Evaluating Cardiovascular Involvement in Patients with Primary and Lupus Nephritis. 145
Renal complications in oncohematologic patients. 144
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair. 143
Regenerative medicine: does Erythropoietin have a role? 140
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 139
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 139
Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin 137
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 137
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 137
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 136
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 136
New options for the management of polycystic kidney disease 136
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 135
LMNA gene mutation as a model of cardiometabolic dysfunction: From genetic analysis to treatment response. 135
Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients 134
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 134
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 133
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 133
Serum levels of apelin-36 are decresed in elderly hospitalized patients with heart failure 130
Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease 129
Renal biopsy: Still a landmark for the nephrologist 129
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 128
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 127
Transient diabetes insipidus in pregnancy, diagnostic role of apelin and copeptin: A case report 125
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 125
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 124
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 120
Vitamin D intoxication in two brothers: be careful with dietary supplements. 119
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1 118
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 117
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 117
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 116
NGAL is a precocious marker of therapeutic response. 115
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 115
Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction 111
Does Erythropoietin Always Win? 107
Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney Disease 105
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 103
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 99
The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis 91
Increase in creatinine for the prediction of contrast-induced nephropathy 90
Surgical Aortic Valve Replacement and Renal Dysfunction: From Acute Kidney Injury to Chronic Disease 89
New available biomarkers to face a worldwide emergency: The childhood obesity 88
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 87
Obestatin: an interesting but controversial gut hormone. 85
Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum. 85
The future of phosphate binders: a perspective on novel therapeutics 83
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 81
Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy 81
Totale 14.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/2022789 6 88 11 46 40 7 53 40 9 173 86 230
2022/20232.048 146 229 95 149 176 197 14 127 849 11 38 17
2023/2024626 33 70 22 53 49 259 7 22 8 37 7 59
2024/20252.414 42 26 49 142 85 103 87 461 568 196 265 390
2025/20267.871 444 503 622 539 656 1.525 969 1.062 1.027 331 174 19
Totale 15.542